Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Australian Government IP Australia
Additional fields:

Trade mark 2475598

Words DEL-DESIRAN
Image
Image description
Status registered: Registered/protected
Priority date 05 Apr 2024 (Convention)
Classes 5, 42
Kind Word
Dates
Renewal due 20 Aug 2034
Registration advertised / published 09 Dec 2025
Entered on Register 09 Dec 2025
Acceptance advertised / published 02 Oct 2025
Acceptance 02 Oct 2025
Filing 20 Aug 2024
Registered from 20 Aug 2024

Owner Address for service
Avidity Biosciences, Inc.
Davies Collison Cave Pty Ltd

Goods & Services
Class 5: Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Class 42: Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

Endorsements

It is a condition of registration that any use in respect of pharmaceuticals will be limited to such goods containing substances belonging to the pharmacological group designated by the International Non-Proprietary Name stem -SIRAN.

Convention details
Date 05 Apr 2024
Number 98/486,061
Country UNITED STATES OF AMERICA
Goods & Services
Class 5:
Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Class 42:
Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology

Indexing constituents
Word Image